For Researchers

The Foundation Fighting Blindness contributes millions of dollars per year to vision research projects being conducted at hospitals and universities across Canada.

These funds are distributed through our Operating Grant and Career Transition Award programs to exceptional research teams focused on understanding, preserving and restoring vision.

If you are a Canadian vision scientist interested in applying for one of our grant programs, please fill out the applicable forms below. All submissions are reviewed by our expert Scientific Advisory Board.

FFB Grants

Operating Grant Program

Our Operating Grant Program is an investigator-driven competition open to scientists appointed at Canadian universities and hospitals. Submitted proposals are subject to systematic peer-review by our Scientific Advisory Board.

The amount and duration of our Operating Grant awards will be commensurate with the needs and merit of the grant proposal. Typically, each of our operating grant awards provide between $50,000-100,000 per year, for a period of 1-3 years. Funding of more than $100,000 per year will not be awarded.

The 2016 Operating Grant competition is now open and will adhere to the following schedule:

Jan. 29, 2016  |  Letter of Intent (LOI) submission deadline
Feb. 19, 2016  |  All applicants notified of the status of their LOI proposal
Apr. 1, 2016  |  Full grant proposal submission deadline
Jun. 1, 2016  |  Scientists notified about the outcome of their proposal
Jul. 1, 2016  |  Funding cycle begins

Please direct questions to Mary Sunderland, Director of Research & Education at

Forms and Applications:
2016 Guidelines for the Allocation of Funds 
2016 Letter Of Intent PDF
2016 Operating Grant Instructions PDF
2016 Operating Grant Form – Section 1 PDF
2016 Operating Grant Budget Module – Section 7 PDF

Submission Instructions
If your application file is larger than 5MB, please submit it using our Dropbox File Request. Be sure to include your name and institution as part of the file name.

If your application file is less than 5MB in size, please use the submit application button below. If you encounter issues when uploading, please contact

Submit Application

All fields marked with an asterisk (*) are required

Name *
Email *
Institution *
Upload full application *

FFB Policies & Positions

Patent Rights Policy

Created and Implemented September 17, 2014

The Foundation Fighting Blindness (FFB) has implemented a patent rights policy for FFB-funded research. The policy can be downloaded here:


Stem Cell Research

Created March 22, 2010

Stem cell research holds promise for finding treatments for various retinal dystrophies. The Foundation Fighting Blindness (FFB) is committed to finding treatments for retinal dystrophies and supports stem cell research as per the Assisted Human Reproduction Act (AHRA), which became law in Canada in March 2004. The Act and its framework ensure the consistent and regulated conduct of research, which balances respect for human life and potential for modern science. The FFB acknowledges the highly sensitive and ethical issues addressed by the Act concerning embryonic stem cell research, and supports efforts to identify alternative sources for therapeutic applications. The FFB respects all points of view on this important topic.

For details about Assisted Human Reproduction in Canada visit

If you wish not to support embryonic stem cell research, your donation to the FFB can be directed to alternative sources for therapeutic applications, such as gene therapy or to education and public awareness.

Indirect Costs

Created May 2007

The Foundation Fighting Blindness does not provide funds for indirect costs associated with research. While the Foundation recognizes that these are indeed legitimate expenditures, we believe the funding of such costs is the responsibility of governments and/or research institutions – not donors.

The Foundation is a member in good standing of the Health Charities Coalition of Canada (HCCC). All HCCC members abide by this funding policy. See the HCCC position statement on indirect costs.